SCHEMBL1126071

SCHEMBL1126071

COc1cc(OC)c(Cl)c(-c2ccc(C(=O)Nc3ccc(CN(C)CCN(C)C)cn3)c3nccnc23)c1Cl.Cc1ccc(N)nc1

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 20/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12678322 0.92 FGFR3 (0.83) FGFR3
SCHEMBL1126391 0.87 FGFR3 (0.75) FGFR3
SCHEMBL1126344 0.86 FGFR3 (0.61) FGFR3
SCHEMBL1126165 0.85 FGFR3 (0.71) FGFR3
SCHEMBL1126739 0.84 FGFR3 (0.82) FGFR3
SCHEMBL1126100 0.83 FGFR3 (0.78) FGFR3
SCHEMBL1126318 0.83 FGFR3 (1.00) FGFR3
SCHEMBL17023151 0.83 FGFR3 (0.68) FGFR3
SCHEMBL1126353 0.83 FGFR3 (0.81) FGFR3
SCHEMBL3352641 0.83 FGFR3 (0.70) FGFR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2282995-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS Novartis AG (CH) 2011-02-16 EP claimed